Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-000956
Filing Date
2024-02-15
Accepted
2024-02-15 16:06:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4871
  Complete submission text file 0001950047-24-000956.txt   6383
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Subject) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38959 | Film No.: 24643824
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1305 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address
Valantine Hannah (Reporting) CIK: 0001855608 (see all company filings)

Type: 144